Where does spinal cord stimulation fit into the international guidelines for refractory painful diabetic neuropathy? a consensus statement
Methodological detailsexpert panel, verbal consensus, Each participant voiced their opinion after reviewing available data; verbal consensus reached during the meeting (December 10, 2022)
- Expert panel
- Verbal consensus
- Each participant voiced their opinion after reviewing available data; verbal consensus reached during the meeting (December 10, 2022)
Recommendations
As issued by the authors
For refractory PDN, opioids are a high-risk option that do not provide a long-term solution and should not be used
For appropriately selected individuals, spinal cord stimulation (SCS) is an effective, safe and durable treatment option
High-frequency SCS (10 kHz) shows strong efficacy and improves quality of life
Strict screening criteria should be used to prioritize candidates for SCS
Original publication
Where does spinal cord stimulation fit into the international guidelines for refractory painful diabetic neuropathy? a consensus statement. Diabetes Res Clin Pract. Published December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →